DalsnaFinance › IPOs › Ovid Therapeutics › IPO
Ovid Therapeutics Inc. completed its initial public offering on NASDAQ on May 5, 2017, pricing at $15.00 a share.
| Ticker | OVID |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 5, 2017 |
| Offering price | $15.00 |
| Shares offered | 5,000,000 |
| Total raised | $75M |
Ovid Therapeutics Inc. sold 5,000,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $75 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $75 million total recorded for the deal.
Ovid Therapeutics Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Ovid Therapeutics Inc.. This page is general information, not investment advice.